Enteroclausi FFS Suspension contains Bacillus clausii spores (2 million spores per dose), a probiotic agent used to restore and maintain the natural balance of intestinal microflora. It is indicated for the prevention and treatment of acute and chronic diarrhea, including antibiotic-associated diarrhea, by replenishing beneficial bacteria in the gastrointestinal tract. Bacillus clausii is a non-pathogenic, spore-forming bacterium that survives gastric acidity and colonizes the intestine, thereby inhibiting the growth of pathogenic microorganisms and enhancing the gut’s natural defense mechanisms. Enteroclausi FFS Suspension is particularly useful in patients undergoing antibiotic therapy, which often disrupts normal intestinal flora, leading to dysbiosis and gastrointestinal disturbances. The formulation is suitable for both adults and children, providing a safe and effective adjunct to conventional treatments for diarrhea and other gastrointestinal disorders. Administration is oral, with dosage tailored according to the severity of the condition and patient age. Enteroclausi FFS Suspension is generally well tolerated, with minimal adverse effects reported. It is important to follow prescribed dosing instructions and consult a healthcare professional before use, especially in immunocompromised individuals or those with underlying health conditions.